42
Participants
Start Date
September 16, 2014
Primary Completion Date
September 25, 2018
Study Completion Date
September 25, 2018
CC-220
0.3 mg oral capsules once every other day with or without food
CC-220
Subjects will receive 0.3 mg oral capsules every day with or without food
CC-220
CC-220 oral capsules 0.6 mg and 0.3 mg on alternating days with or without food
CC-220
CC-220 oral capsule 0.6 mg QD with or without food
Placebo
Matching oral placebo daily
NYU Langone Medical Center, New York
Feinstein Institute For Medical Research, Manhasset
Northwell Health / Division of Rheumatology, Lake Success
Univ of Rochester Medical Center, Rochester
UMPC Lupus Center of Excellence, Pittsburgh
Altoona Center for Clinical Research, Duncansville
University of Pennsylvania Health Systems, Philadelphia
Virginia Clinical Research, Inc., Norfolk
DJL Clinical Research, Charlotte
Low Country Rheumatology PA, Charleston
Arthritis Research and Treatment Center, Stockbridge
Emory University School of Medicine, Atlanta
Advanced Medical Research, Atlanta
Vipul Joshi, MD, PA, dba Bay Area Arthritis and Osteoporosis, Brandon
University of Alabama at Birmingham, Birmingham
Ohio State University Medical Center, Columbus
University of Toledo Medical Center, Toledo
MetroHealth Medical Systems, Cleveland
Northshore University Health System, Skokie
Northwestern Medical Group; Department of Dermatology, Chicago
Southern Illinois University School of Medicine, Springfield
Tulane University Health Sciences Center, New Orleans
Oklahoma Medical Research Foundation, Oklahoma City
University of Texas Health Science Center at Houston, Houston
Austin Regional Clinic, Austin
Arizona Arthritis and Rheumatology Research, PLLC, Paradise Valley
University of Arizona Clinical and Translational Science Research Center, Tucson
Dermatology Research Associates, Los Angeles
Clinical Science Institute, Santa Monica
Los Angeles Biomedical Research Institute at Harbor - UCLA, Torrance
Inland Rheumatology Clinical Trials, Upland
UCSD Center for Innovative Therapy, La Jolla
East Bay Rheumatology Medical Group Inc., San Leandro
Seattle Arthritis Clinic, Seattle
Columbia Presbyterian Medical Center, New York
Lead Sponsor
Celgene
INDUSTRY